- Health Canada DPD: PROLOPA CAP 100-25 (HOFFMANN-LA ROCHE LIMITED, DIN 00386464) · product monograph (PDF)
- Health Canada DPD: PROLOPA CAP 200-50 (HOFFMANN-LA ROCHE LIMITED, DIN 00386472) · product monograph (PDF)
Links only. These regulators' terms do not clearly permit reproducing the documents, so no text is shown here. Check the Philippine package insert in the products table.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Tablet: 100 mg/25 mg, 200 mg/50 mg
Registered products in the Philippines
2 products registered with the Food and Drug Administration (FDA) Philippines list Benserazide + Levodopa as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
MadoparLevodopa + Benserazide (As Hydrochloride) | 200 mg/ 50 mg TabletAmber Bottle x 100's | Rx | Delpharm Milano S.r.Litaly | Roche (Philippines), Inc. | DR-XY40579 | Aug 25, 2027 | |
Madopar HBSLevodopa + Benserazide (As Hydrochloride) | 100 mg/ 25 mg TabletAmber Bottle x 100 caps Box of 1's | Rx | Delpharm Milano S.r.Litaly | Roche (Philippines), Inc. | DR-XY40316 | Aug 25, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .